Active Ingredient History

  • Now
Amibegron (SR-58,611A) was a drug developed by Sanofi-Aventis which acts as a selective agonist for the β3 adrenergic receptor. It is the first orally active β3 agonist developed that is capable of entering the central nervous system, and has antidepressant and anxiolytic effects.   Wikipedia

  • SMILES: CCOC(=O)COc1ccc2CC[C@@H](Cc2c1)NC[C@H](O)c3cccc(Cl)c3
  • Mol. Mass: 403.91
  • ALogP: 3.46
  • ChEMBL Molecules:
More Chemistry
acetic acid, ((7-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)-5,6,7,8-tetrahydro-2-naphthalenyl)oxy)-, ethyl ester, hydrochloride, (r-(r*,s*))- | amibegron | amibegron hcl | amibegron hydrochloride | sr 58611 | sr-58611 | sr58611a | sr 58611a | sr-58611a


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue